July 4 (Reuters) - Cyclopharm Ltd (CYC) :
- 1H 2022 BUSINESS UPDATE - RECORD REVENUES
- SEES 1H FY 2022 TOTAL UNAUDITED GROUP SALES REVENUE TO BE ABOUT A$11.3 MILLION
- NET CASH POSITION AT HALF YEAR EXPECTED TO BE A$26 MILLION
- 1H FY 2022 REVENUES FROM PREDOMINANTLY RECURRING PATIENT ADMINISTRATION SETS CONSUMABLES EXPECTED TO BE 21% HIGHER THAN PCP
News: CYC Cyclopharm Says Expects 1H FY 2022 Total Unaudited Group Sales Revenue To Be About A$11.3...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
-0.030(2.75%) |
Mkt cap ! $117.8M | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.05 | $58.20K | 54.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4760 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| CYC (ASX) Chart |